scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0733-8619(18)31105-8 |
P698 | PubMed publication ID | 6503939 |
P2093 | author name string | Brooks BR | |
Walker DL | |||
P2860 | cites work | Failure of high dose 5-iodo-2'-deoxyuridine in the therapy of herpes simplex virus encephalitis. Evidence of unacceptable toxicity | Q33333180 |
Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy | Q34201921 | ||
Prevalence of Antibodies in Human Sera against JC Virus, an Isolate from a Case of Progressive Multifocal Leukoencephalopathy | Q34213119 | ||
Progressive multifocal leukoencephalopathy: electron microscope study of four cases | Q36566737 | ||
Identity of a newly isolated human polyomavirus from a patient with progressive multifocal leucoencephalopathy | Q36659974 | ||
Occurrence of IgM antibodies against BK and JC polyomaviruses during pregnancy | Q37074316 | ||
Rapid detection and identification of JC virus and BK virus in human urine by using immunofluorescence microscopy | Q37322793 | ||
Our evolving understanding of progressive multifocal leukoencephalopathy | Q39939859 | ||
Progressive multifocal leukoencephalopathy: Failure of response to transfer factor and cytarabine | Q40167661 | ||
Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: Use of virus-containing cells in the urine to assess response to therapy | Q40187400 | ||
Detection of Polyoma Virus DNA in PML-Brain Tissue by (in situ) Hybridization | Q40198959 | ||
PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY AND PRIMARY HYPERSPLENISM. WITH A NOTE ON THE ASSOCIATION BETWEEN DISEASE OF THE RETICULOENDOTHELIAL SYSTEM AND PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY. | Q41293042 | ||
Computed Tomographic Guidance Stereotaxis in the Management of Intracranial Mass Lesions | Q41448026 | ||
Progressive multifocal leukoencephalopathy (PML): in vitro cell-mediated immune responses to mitogens and JC virus | Q41613701 | ||
Brain biopsy in the diagnosis of cerebral mycosis fungoides | Q42723353 | ||
Etiology of progressive multifocal leukoencephalopathy. Identification of papovavirus | Q43430246 | ||
Distribution of Nonintegrated DNA from JC Papovavirus in Organs of Patients with Progressive Multifocal Leukoencephalopathy | Q44020600 | ||
Computerized Tomography in Progressive Multifocal Leukoencephalopathy | Q44291755 | ||
Progressive multifocal leukoencephalopathy: immunofluorescent demonstration of simian virus 40 antigen in CSF cells and response to cytarabine therapy | Q44437249 | ||
Are astrocytes infected in progressive multifocal leukoencephalopathy (PML)? | Q44447475 | ||
Subacute multifocal leukoencephalopathy with widespread intranuclear inclusions | Q44558321 | ||
Multiple central nervous system infections in progressive multifocal leukoencephalopathy | Q44763405 | ||
Prevalence Rate and Age of Acquisition of Antibodies against JC Virus and BK Virus in Human Sera | Q45798650 | ||
Multifocal varicella-zoster virus leukoencephalitis temporally remote from herpes zoster | Q45802269 | ||
Primary progressive multifocal leukoencephalopathy. A central nervous system disease caused by a slow virus | Q45813167 | ||
Cytarabine treatment of progressive multifocal leukoencephalopathy. Clinical course and detection of virus-like particles after antiviral chemotherapy | Q45818216 | ||
Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy | Q45821061 | ||
Progressive multifocal leukoencephalopathy. A virus disease? | Q45825776 | ||
Papovavirus of JC type in progressive multifocal leukoencephalopathy. Rapid identification and subsequent isolation | Q46208449 | ||
The abnormal brain scan in demyelinating diseases | Q47889967 | ||
Progressive multifocal leukoencephalopathy. A cause of visual loss | Q48302647 | ||
Diagnosis of progressive multifocal leukoencephalopathy by computed tomography | Q48329153 | ||
Absence of imune deficiencies in a case of progressive multifocal leukoencephalopathy | Q48367261 | ||
JC Papovavirus in progressive multifocal leukoencephalopathy | Q48385842 | ||
Progressive multifocal leukoencephalopathy and cytarabine. Remission with treatment | Q48625543 | ||
Progressive multifocal leukoencephalopathy after renal transplantation. Demonstration of Papova-like virions | Q48812371 | ||
Primary progressive multifocal leukoencephalopathy: A case report | Q48866816 | ||
Recovery of papovavirus in cell culture explants of brain tissue from case of progressive multifocal leukoencephalopathy | Q48911322 | ||
Spontaneous progressive multifocal leukoencephalopathy | Q48920167 | ||
Progressive multifocal leukoencephalopathy. Identification of virions in paraffin-embedded tissues | Q48932996 | ||
Distribution of papovavirus, myelin-associated glycoprotein, and myelin basic protein in progressive multifocal leukoencephalopathy lesions | Q48963075 | ||
The EEG in progressive multifocal leukoencephalopathy | Q49071173 | ||
Progressive multifocal leukoencephalopathy; positive brain scan | Q51119074 | ||
Polyoma-like virions in a human demyelinating disease. | Q51217128 | ||
PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHY ASSOCIATED WITH MULTIPLE MYELOMA. | Q51274496 | ||
Cerebral demyelination associated with polycythemia vera. | Q51290071 | ||
The association of progressive multifocal leukoencephalopathy and sarcoidosis. | Q52216682 | ||
Progressive multifocal leukoencephalopathy: A burnt-out case | Q53966874 | ||
Cerebellar Form of Progressive Multifocal Leukoencephalopathy (PML) | Q66940106 | ||
Case Report Simultaneous fungal and viral infection of the central nervous system | Q67027603 | ||
Pituitary function after removal of microadenomas for Cushing's disease | Q67344831 | ||
Progressive multifocal leukoencephalopathy and cryptococcal meningitis with systemic lupus erythematosus and thymoma | Q67648166 | ||
Letter: Progressive multifocal leucoencephalopathy successfully treated with cytosine arabinoside | Q67783112 | ||
"Spontaneous" progressive multifocal leukoencephalopathy. Immunologic aspects | Q68501578 | ||
Progressive multifocal leukoencephalopathy | Q68629845 | ||
Progressive multifocal leukoencephalopathy following kidney transplantation | Q69354630 | ||
Progressive multifocal leucoencephalopathy: Detection of papovavirus jc in kidney tissue | Q70154252 | ||
Primary cerebellopontine progressive multifocal leukoencephalopathy diagnosed premortem by cerebellar biopsy | Q70329331 | ||
Progressive multifocal leukoencephalopathy in myasthenia gravis | Q70329345 | ||
Progressive multifocal leukoencephalopathy: failure of cytarabine therapy | Q70671802 | ||
Progressive multifocal leukoencephalopathy in a patient with Hodgkin's disease | Q71431107 | ||
Reticulum cell sarcoma and progressive multifocal leukoencephalopathy following renal transplantation | Q72131426 | ||
Progressive multifocal leukoencephalopathy (PML). I. Investigation of the immunologic status of a patient with lymphosarcoma and PML | Q72526622 | ||
Morphological demonstration of the first phase of polyomavirus replication in oligodendroglia cells of human brain in progressive multifocal leukoencephalopathy (PML) | Q72843817 | ||
Progressive Multifocal Leukoencephalopathy in a Male Homosexual with T-Cell Immune Deficiency | Q72961171 | ||
Progressive multifocal leukoencephalopathy | Q76493778 | ||
LEUKOENCEPHALOPATHY AND DERMATOMYOSITIS IN HODGKIN'S DISEASE. A CASE REPORT | Q76721795 | ||
Progressive multifocal leukoencephalopathy | Q79266921 | ||
P433 | issue | 2 | |
P921 | main subject | progressive multifocal leukoencephalopathy | Q704930 |
P304 | page(s) | 299-313 | |
P577 | publication date | 1984-05-01 | |
P1433 | published in | Neurologic Clinics | Q15756619 |
P1476 | title | Progressive multifocal leukoencephalopathy | |
P478 | volume | 2 |
Q45488111 | A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal fluid, blood, serum, and urine |
Q38268951 | A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy |
Q30351230 | AIDS-associated progressive multifocal leukoencephalopathy : current management strategies. |
Q57176786 | AIDS-associated progressive multifocal leukoencephalopathy revealed by new-onset seizures |
Q37462968 | An evidence-based review of natalizumab therapy in the management of Crohn's disease. |
Q35112663 | An overview: Human Polyomavirus JC Virus and its Associated Disorders |
Q45723886 | Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment |
Q70551464 | Balint's syndrome in subacute HIV encephalitis |
Q33590522 | Buspirone in progressive myoclonus epilepsy |
Q33597052 | CNS elevation of vascular and not mucosal addressin cell adhesion molecules in patients with multiple sclerosis |
Q45400146 | Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis |
Q41033890 | Clinical presentation, diagnosis and therapy of progressive multifocal leukoencephalopathy |
Q26775837 | Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphoma |
Q36991114 | Detection of Malawi polyomavirus sequences in secondary lymphoid tissues from Italian healthy children: a transient site of infection |
Q35012056 | Determinants of survival in progressive multifocal leukoencephalopathy |
Q40039520 | Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies |
Q48762536 | Diagnostic criteria and clinical procedures in HIV-1 associated progressive multifocal leukoencephalopathy |
Q80831430 | Diffusion-weighted imaging in patients with progressive multifocal leukoencephalopathy |
Q41393684 | Drug-induced progressive multifocal leukoencephalopathy: Lessons learned from contrasting natalizumab and rituximab. |
Q48222094 | Early pathological changes in progressive multifocal leukoencephalopathy: a report of two asymptomatic cases occurring prior to the AIDS epidemic |
Q77742233 | Enhancing progressive multifocal leukoencephalopathy: an indicator of improved immune status? |
Q34087788 | Epidemiological evidence and molecular basis of interactions between HIV and JC virus |
Q55512693 | Exploring the role of NCCR variation on JC polyomavirus expression from dual reporter minicircles. |
Q39905306 | Exploring the virome of cattle with non-suppurative encephalitis of unknown etiology by metagenomics |
Q64255951 | Favorable Response to Mirtazapine in John Cunningham Virus-related Gray Matter Lesion in a Patient with Human Immunodeficiency Virus |
Q44209549 | HIV-associated PML presenting as epilepsia partialis continua |
Q38868240 | Host cell virus entry mechanisms enhance anti-JCV-antibody switch in natalizumab-treated multiple sclerosis patients. |
Q92801957 | Human Polyomavirus JCPyV and Its Role in Progressive Multifocal Leukoencephalopathy and Oncogenesis |
Q35931809 | Human polyomavirus receptor distribution in brain parenchyma contrasts with receptor distribution in kidney and choroid plexus. |
Q39877627 | Identification and characterization of mefloquine efficacy against JC virus in vitro |
Q37028699 | Immune reconstitution is not a prognostic factor in progressive multifocal leukoencephalopathy |
Q37371745 | Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab |
Q35746926 | In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection |
Q30908652 | Infection risk in patients on multiple sclerosis therapeutics |
Q37180581 | Inflammatory pseudotumor associated with HIV, JCV, and immune reconstitution syndrome. |
Q39601983 | Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells |
Q34263748 | Investigation of pre-diagnostic virological markers for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patients |
Q35598327 | JC papovavirus large tumor (T)-antigen expression in brain tissue of acquired immune deficiency syndrome (AIDS) and non-AIDS patients with progressive multifocal leukoencephalopathy |
Q45786584 | JC virus DNA in cerebrospinal fluid of human immunodeficiency virus—infected patients: Predictive value for progressive multifocal leukoencephalopathy |
Q24643911 | JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy |
Q37183930 | JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy |
Q33827403 | JC virus granule cell neuronopathy onset two months after chemotherapy for low-grade lymphoma |
Q35899152 | JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy. |
Q39878385 | JC virus-induced Progressive Multifocal Leukoencephalopathy |
Q39451503 | JCV agnoprotein-induced reduction in CXCL5/LIX secretion by oligodendrocytes is associated with activation of apoptotic signaling in neurons. |
Q45434190 | Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy |
Q42800734 | Mefloquine Treatment in a Patient Suffering from Progressive Multifocal Leukoencephalopathy after Umbilical Cord Blood Transplant |
Q45721249 | Molecular analysis of JC virus genotypes circulating among the Italian healthy population |
Q24619923 | Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain |
Q28270413 | Monoclonal antibodies and progressive multifocal leukoencephalopathy |
Q37568787 | Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project |
Q36622383 | Natalizumab and progressive multifocal leucoencephalopathy |
Q34409340 | Natalizumab in the treatment of multiple sclerosis |
Q34619064 | Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring |
Q37168655 | Neuro-ophthalmic manifestations of human immunodeficiency virus infection. |
Q44564343 | Neurologic complications of Hodgkin's disease: a case history |
Q36334043 | Neurosurgical aspects of human immunodeficiency virus infection. |
Q41542237 | New aspects in the pathogenesis of polyomavirus-induced disease. |
Q30352753 | New trends in progressive multifocal leukoencephalopathy |
Q38485170 | Nonradioactive in situ hybridization in progressive multifocal leukoencephalopathy |
Q71108637 | Ophthalmologic manifestations of acquired immune deficiency syndrome-associated progressive multifocal leukoencephalopathy |
Q30613846 | PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section |
Q35225109 | Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain |
Q52587612 | Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned. |
Q37828002 | Pathogenesis of progressive multifocal leukoencephalopathy--revisited |
Q37224291 | Potential mechanisms of the human polyomavirus JC in neural oncogenesis |
Q73239403 | Progressive Multifocal Leukoencephalopathy |
Q74256276 | Progressive Multifocal Leukoencephalopathy |
Q41924854 | Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies: A Review |
Q30332766 | Progressive Multifocal Leukoencephalopathy in Acquired Immunodeficiency Syndrome: Explaining the High Incidence and Disproportionate Frequency of the Illness Relative to Other Immunosuppressive Conditions |
Q42611496 | Progressive multifocal leucoencephalopathy in AIDS camouflaged with catatonia: A wolf in sheep's clothing |
Q81521025 | Progressive multifocal leukoencephalopathy |
Q82029803 | Progressive multifocal leukoencephalopathy |
Q30579376 | Progressive multifocal leukoencephalopathy |
Q44545122 | Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS). A neuropathological autopsy study of 21 cases |
Q33383576 | Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project |
Q74318254 | Progressive multifocal leukoencephalopathy an chronic lymphocytic leukemia |
Q36458748 | Progressive multifocal leukoencephalopathy and multiple sclerosis: lessons from natalizumab |
Q37798242 | Progressive multifocal leukoencephalopathy and newer biological agents |
Q33763351 | Progressive multifocal leukoencephalopathy and other forms of JC virus disease |
Q102220458 | Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease |
Q35701501 | Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project |
Q36773981 | Progressive multifocal leukoencephalopathy in AIDS: a clinicopathologic study and review of the literature |
Q73249975 | Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team |
Q69967479 | Progressive multifocal leukoencephalopathy in Wegener's granulomatosis in relation to therapy with cyclosporin A |
Q36829990 | Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution |
Q38153637 | Progressive multifocal leukoencephalopathy in multiple sclerosis |
Q47579884 | Progressive multifocal leukoencephalopathy in the absence of immunosuppression |
Q30365798 | Progressive multifocal leukoencephalopathy. |
Q62831824 | Progressive multifocal leukoencephalopathy: a retrospective study of 30 cases |
Q44045441 | Progressive multifocal leukoencephalopathy: diffusion-weighted imaging and pathological correlations. |
Q36619370 | Regulation of JC virus expression in B lymphocytes |
Q41964449 | Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a man with AIDS. |
Q38001435 | Review on the relationship between human polyomaviruses-associated tumors and host immune system |
Q39615725 | Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy |
Q57583802 | Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders |
Q53442107 | Spinal cord progressive multifocal leukoencephalopathy detected premortem by MRI. |
Q50043312 | Susceptibility of Primary Human Choroid Plexus Epithelial Cells and Meningeal Cells to Infection by JC Virus. |
Q45389810 | The bone marrow, B cells, and JC virus |
Q30403035 | The changing landscape of progressive multifocal leukoencephalopathy |
Q37141010 | The role of polyomaviruses in human disease |
Q36436769 | The role of sialic acid in human polyomavirus infections |
Q90288758 | Treatment of Progressive Multifocal Leukoencephalopathy Using Immune Restoration |
Q34087794 | Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside |
Q26823444 | Treatment-related progressive multifocal leukoencephalopathy: current understanding and future steps |
Q36672687 | Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature |
Q38044681 | Update on progressive multifocal leukoencephalopathy |
Q89520910 | Use of check-point inhibitors in the treatment of progressive multifocal leukoencephalopathy |
Q69852467 | Viral infections in the acquired immunodeficiency syndrome |
Q82421983 | [Role of immunity in the development of progressive multifocal leukoencephalopathy: a report of three patients with type B lymphoma and humoral immunodeficiency and six others with acquired immunodeficiency syndrome] |
Search more.